June 28 (Reuters) - Orphazyme A/S ORPHA.CO :
* ANNOUNCES RESTRUCTURING TO FOCUS RESOURCES ON SUPPORTING A
PATH
FORWARD FOR ARIMOCLOMOL IN NPC
* RESULTING COST SAVINGS INCLUDE AN APPROXIMATE TWO THIRDS
REDUCTION IN OUR GLOBAL WORKFORCE
* ORPHAZYME'S FINANCIAL OUTLOOK REMAINS UNCHANGED FOR 2021
* CO WILL SCALE BACK ITS GLOBAL ORGANIZATION, INCLUDING
TEAMS
BASED IN U.S. AND EUROPE, WITH PURPOSE OF REDUCING NUMBER OF
EMPLOYEES
* REMAINS COMMITTED TO PURSUING REGULATORY APPROVAL IN
EUROPE,
ASSESSING A PATH FORWARD FOR ARIMOCLOMOL IN U.S.
* IN DENMARK, WILL IMMEDIATELY INITIATE NEGOTIATIONS UNDER
DANISH
ACT ON COLLECTIVE REDUNDANCIES AND ACT ON INFORMATION AND
CONSULTATION
Source text for Eikon: ID:nGNE5khyvQ
Further company coverage: ORPHA.CO
((Reuters.Briefs@thomsonreuters.com;))